CIK 0001177648
- Non-accelerated filer
- Smaller reporting company
ENANTA PHARMACEUTICALS INC
Sign in to watch- Ticker
- ENTA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Sep 30
- Entity type
- Operating
- EIN
- 043205099
- Phone
- +1 617-607-0800
- Business address
- 4 KINGSBURY AVENUE, WATERTOWN, MA, 02472
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2019-02-12 | Gardiner Nathaniel S. Sr. VP & General Counsel | Grant or award | +10,000 | 31,827 | ||
| 2019-02-12 | Gardiner Nathaniel S. Sr. VP & General Counsel | Shares withheld for taxes | −4,579 | $88.88 | $407K | 27,248 |
| 2019-02-12 | MELLETT PAUL J Treasurer and CFO | Grant or award | +4,200 | 84,618 | ||
| 2019-02-12 | MELLETT PAUL J Treasurer and CFO | Grant or award | +10,500 | 95,118 | ||
| 2019-02-12 | MELLETT PAUL J Treasurer and CFO | Shares withheld for taxes | −4,890 | $88.88 | $435K | 90,228 |
| 2019-02-12 | Luly Jay R. President and CEO | Grant or award | +14,400 | 615,924 | ||
| 2019-02-12 | Luly Jay R. President and CEO | Grant or award | +36,000 | 651,924 | ||
| 2019-02-12 | Luly Jay R. President and CEO | Shares withheld for taxes | −20,730 | $88.88 | $1.8M | 631,194 |
| 2019-02-12 | Or Yat Sun Sr. VP & CSO | Sale | −6,297 | $90.07 | $567K | 301,916 |
| 2019-02-12 | Or Yat Sun Sr. VP & CSO | Grant or award | +4,500 | 306,416 | ||
| 2019-02-12 | Or Yat Sun Sr. VP & CSO | Grant or award | +11,250 | 317,666 | ||
| 2019-02-12 | Or Yat Sun Sr. VP & CSO | Shares withheld for taxes | −6,993 | $88.88 | $622K | 310,673 |
| 2019-02-12 | Golumbeski George Director | Exercise or conversion | +3,728 | $25.58 | $95K | 3,728 |
| 2019-02-12 | Golumbeski George Director | Exercise or conversion | +7,500 | $29.02 | $218K | 11,228 |
| 2019-02-12 | Golumbeski George Director | Sale | −11,228 | $90.07 | $1.0M | 0 |
| 2019-02-12 | Golumbeski George Director | Exercise or conversion · Stock Option (Right to Buy) | −3,728 | 0 | ||
| 2019-02-12 | Golumbeski George Director | Exercise or conversion · Stock Option (Right to Buy) | −7,500 | 0 | ||
| 2019-02-12 | CARTER BRUCE L A Director | Exercise or conversion | +5,000 | $23.40 | $117K | 5,000 |
| 2019-02-12 | CARTER BRUCE L A Director | Sale | −5,000 | $90.00 | $450K | 0 |
| 2019-02-12 | CARTER BRUCE L A Director | Exercise or conversion · Stock Option (Right to Buy) | −5,000 | 1,546 |
Page 24 of 31 · 619 trades